{
  "Risks Related to Our Business, Industry and Operations": [
    "Intense competition",
    "Manufacturing disruption risks",
    "Third-party dependency",
    "Product quality risks",
    "COVID-19 pandemic impact"
  ],
  "Risks Related to Government Regulation and Legal Proceedings": [
    "Market competition pressures",
    "Legal proceedings exposure",
    "Product quality risks",
    "Regulatory compliance failure",
    "Tax regulation changes"
  ],
  "Risks Related to Our Intellectual Property": [
    "Intellectual property protection risk"
  ],
  "Risks Related to Product Development, Regulatory Approval and Commercialization": [
    "R&D investment risks"
  ],
  "Risks Related to Financial and Economic Market Conditions": [
    "Currency exchange risks",
    "new factor: Anti-bribery compliance risk",
    "Geopolitical instability risk"
  ],
  "Risks Related to the Planned Separation of our Consumer Health Business": [
    "Strategic alliances performance",
    "Tax liabilities exposure"
  ],
  "Other Risks": [
    "Workforce retention challenges",
    "Climate change effects",
    "Cybersecurity breach risks",
    "Data protection laws",
    "new factor: Succession planning risk"
  ]
}